-
(EDMD). CP provides pharmacokinetic (PK) and pharmacodynamic (PD) expertise. M&S provides model-driven PK and PK/PD quantitative pharmacology expertise. EDMD leads early clinical strategies and provides
-
, we are driven by just one goal - to lessen the severity and impact of influenza, which can reach epidemic or even pandemic proportions with life-threatening consequences. Every year our influenza
-
, and support the strategic dissemination of data that advances patient care worldwide. Through a phased training model, the program emphasizes both foundational knowledge and leadership development
-
education and research model apart. With leading companies at the table from day one, we are creating an agile workforce prepared to thrive in a competitive landscape powered by artificial intelligence as a
-
challenges and opportunities made possible by human-machine collaboration. The Institute provides a framework to design, implement, and scale AI-driven technologies in ways that make a true difference to